Are you a healthcare professional, clinical researcher or data scientist interested in drug safety research? If so, you know how vital understanding a drug’s adverse effects is to maximize its […]
While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such investigation is hindered by the difficulty in finding and combining […]
In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types. […]
While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such investigation is hindered by the difficulty in finding and combining […]
There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't need a script to fetch the data you want. This […]
There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't need a script to fetch the data you want. This […]
Within QIAGEN Ingenuity Pathway Analysis (IPA), public data sourced from OmicSoft is already processed and standardized, making it easy to jump to the actual research. In this training, we'll show […]
Within QIAGEN Ingenuity Pathway Analysis (IPA), public data sourced from OmicSoft is already processed and standardized, making it easy to jump to the actual research. In this training, we'll show […]
Are you new to QIAGEN IPA or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. […]
QIAGEN’s Ingenuity Pathway Analysis (IPA) is a powerful tool that allows you to upload your omics data and analyze it to identify key biological pathways and mechanisms and regulatory molecules. […]
QIAGEN’s Ingenuity Pathway Analysis (IPA) is a powerful tool that allows you to upload your omics data and analyze it to identify key biological pathways and mechanisms and regulatory molecules. But did you know you can share your analysis results with others? In this 60-minute webinar, we’ll explore the Share Manager and the Collaboration Workspace […]
Many research groups worldwide are investing significant time and resources in studying drug mechanism of action (MOA) and its impact on disease pathology. One critical challenge they encounter is access to a centralized source that contains high-quality, manually curated literature knowledge. To meet this need, we launched QIAGEN Biomedical KB-HD, the expert-curated database backing QIAGEN […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships […]
Watch Now
